Study to Evaluate the Real-World Long-Term Effectiveness of Lanadelumab in Participants With Hereditary Angioedema (HAE) (Q74275749)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Study to Evaluate the Real-World Long-Term Effectiveness of Lanadelumab in Participants With Hereditary Angioedema (HAE)
clinical trial

    Statements

    ENABLE (English)
    0 references
    A Three-year, Non-interventional, Prospective, Multicenter Study to Evaluate the Long-term Effectiveness of Lanadelumab in Real-world Clinical Practice (ENABLE) (English)
    0 references
    0 references
    0 references
    0 references
    31 October 2019
    0 references
    30 April 2024
    0 references
    200
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit